Hypervision Surgical Joins Tech Nation's Upscale 2026 Cohort
Hypervision Surgical has been selected for Upscale 2026, Tech Nation’s growth programme for the UK’s most ambitious post-Series A scaleups.
Read more
Hypervision Surgical has been selected for Upscale 2026, Tech Nation’s growth programme for the UK’s most ambitious post-Series A scaleups.
Read moreHypervision Surgical has attained certification to ISO/IEC 27001:2022 and ISO/IEC 27701:2019, the international standards for information security management and privacy information management.
Read moreHypervision, a pioneer in real-time hyperspectral imaging for surgery, announced the successful closing of its oversubscribed £17m Series A financing round, led by Heal Capital with participation from Angelini Ventures, IP Group, and Daycrest.
Read moreHypervision Surgical is proud to announce that we have been awarded the 2025 Lippmann Award, a global distinction recognising impactful innovation in hyperspectral imaging.
Read moreWhen Life Science Intelligence (LSI) launched its first LSI Europe conference in London in 2022, it marked an inflection point for Hypervision Surgical.
Read moreHypervision secured 2nd place at the 2025 SRS Shark Tank, spotlighting its breakthrough AI-powered spectral imaging platform at the world’s leading digital surgery and robotics forum.
Read more